The NF-κB inhibitor BMS-345541 could abrogate the increase in fibronectin deposition in lung fibroblasts isolated from COPD patients after stimulation with cigarette smoke extracts and TGF-β [31]. The gene discussed is FN1; the disease is chronic obstructive pulmonary disease.